Form D · Other Technology
Exelate, Inc.
New York, NY · CIK 0001550691
Offering snapshot reported Sep 19, 2012 · SEC filing
- Reported sold
- $12M Offering amount: $12M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 7, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 19, 2012 | Initial | $12,000,003 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-184334
Source: Form D, filed Sep 19, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shlomo Dovrat | Director |
| Elad Efraim | Executive |
| Damian Garbaccio | Executive |
| Angela Jin | Executive |
| Martin Nisenholtz | Director |
| Glenn T. Rieger | Director |
| Mark Siegel | Director |
| Evangelos Simoudis | Director |
| Mark Zagorski | Director, Executive |
| Meir Zohar | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
7 West 22 Nd Street, 9 Th Floor
New York, NY, 10010
New York, NY, 10010